This morning’s Science for Breakfast at Medicon Village brought together 93 participants for an inspiring session filled with great discussions and meaningful meetings.
We were honored to have Professor Mika Scheinin, Scientific Advisor, and Ulrika Mårtensson, Director Business Development, share insights into LINK Medical’s growth journey — including the acquisition of CRST and the expansion of our early-phase clinical research units in Turku and Helsinki, Finland.

🔹 Ulrika Mårtensson, Director Business Development, opened the session with an overview of LINK Medical’s broad service offerings — from clinical operations and regulatory affairs to pharmacovigilance, market access, and early-phase research.

🔹 Professor Mika Scheinin, Scientific Advisor, shared insights into our clinical research units in Turku and Helsinki, Finland. These units specialize in early-phase clinical pharmacology studies, including First-in-Human trials, and offer advanced imaging capabilities and access to large healthy volunteer databases
Thank you to everyone who joined us in Lund — your engagement made this celebration truly special! 🧡